Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Homo sapiens

ABSTRACT: RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14

PROVIDER: PRJNA381786 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5419910.fastq.gz	Fastqsanger.gz
	SRR5419911.fastq.gz	Fastqsanger.gz
	SRR5419912.fastq.gz	Fastqsanger.gz
	SRR5419913.fastq.gz	Fastqsanger.gz
	SRR5419914.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Effect of depletion of METTL3 or METTL14 on gene expression in human K562 cell line, a model of chronic myeloid leukemia in the acute myeloid blast phase

Project description:N6-methyladenosine (m6A) RNA methylation is a significant epigenetic modification in mammalian mRNAs, crucial for tumorigenesis and development. Our study shows that the methyltransferases METTL3 and METTL14 are highly expressed in acute myeloid leukemia (AML) patients, excluding those with acute promyelocytic leukemia (APL). Elevated levels of these enzymes correlate with shorter survival rates, indicating their role as adverse prognostic factors in AML. Through comprehensive analysis of RNA-seq data and subsequent experimental validation, the knockdown of METTL3 and METTL14 was found to significantly perturb the p53 signaling pathway. This alteration resulted in the upregulation of both p53 and CDKN1A (p21), as well as an extended half-life of mdm2 mRNAs. Furthermore, METTL3 influences AML cell survival by regulating the MAPK pathway through PGC-1α, which modulates ROS detoxification and acts as an oncogene. In summary, METTL3 and METTL14 are promising targets for AML treatment.

2025-02-22 | GSE282987 | GEO

RNA seq with AML cells (NB4) upon FTO knockdown

Project description:To identify the potential targets genes of FTO in acute myeloid leukemia (AML), we peroformed RNA-seq of NB4 cells with or without FTO knockdown based on Illumina Hiseq system.

2019-04-29 | GSE103494 | GEO

Homo sapiens

Project description:N6-methyladenosine (m6A) sequencing of messenger RNAs in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 [m6A-seq]

| PRJNA381699 | ENA

Homo sapiens

Project description:acute myeloid leukemia (AML)

| PRJNA87151 | ENA

Homo sapiens

Project description:acute myeloid leukemia (AML)

| PRJNA87153 | ENA

N6-methyladenosine (m6A) sequencing of messenger RNAs in acute myeloid leukemia (AML) cells with and without knockdown of FTO

Project description:To identify potential mRNA targets of FTO whose m6A levels are influenced in acute myeloid leukemia (AML) cells, we conducted m6A-seq for mRNA isolated from MA9.3ITD cells with and without knockdown of FTO

2016-12-20 | GSE84944 | GEO

Homo sapiens

Project description:mRNA sequencing in acute myeloid leukemia (AML) cells with and without knockdown of FTO

| PRJNA335858 | ENA

RNA-seq in murine acute myeloid leukemia (AML) cells with and without knockdown of Tet1

Project description:RNA-seq in murine acute myeloid leukemia (AML) cells with and without knockdown of Tet1

| PRJNA479002 | ENA

Quantitative proteomics analysis of acute myeloid leukemia cells after NAT10 knockdown

Project description:RNA modification represents an important post-transcriptional regulatory mechanism in acute myeloid leukemia (AML). Given that the critical function of ac4C in control RNA translation, we sought to investigate the global impact of ac4C on protein expression. To this end, we conducted tandem mass tag (TMT) labeling and quantitative proteomics in MOLM13 AML cells with or without the ac4c writer NAT10 silencing.

2024-08-26 | PXD055119 | Pride

Homo sapiens

Project description:TARGET: Acute Myeloid Leukemia (AML)

| PRJNA89525 | ENA